Circulating tumor cells (CTCs) biomarker evaluation from patients with metastatic breast cancer (MBC) utilizing the TargetSelector™ platform

被引：0
|
作者：
Hamilton, E. P.
Yardley, D. A.
Burris, H. A., III
Shastry, M.
Huynh, L.
Bhikha, L.
Singh, V. M.
机构：
[1] Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN USA
[2] Sarah Cannon Res Inst, Nashville, TN USA
[3] Biocept Inc, San Diego, CA USA
[4] Tennessee Oncol PLLC, Nashville, TN USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P1-01-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-01-16
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Multiple Biomarker Expression in Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients (Pts).
    Somlo, G.
    Hsieh, H. B.
    Curry, D. N.
    Frankel, P.
    Krivacic, R. T.
    Lau, S.
    Lazarus, N.
    Baker, N.
    Swain-Cabriales, S.
    Bruce, R.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 649S - 649S
  • [2] Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) longitudinal monitoring of metastatic breast cancer (MBC).
    Costa, Ricardo Lima Barros
    Rossi, Giovanna
    Mu, Zhaomei
    Austin, Laura Katherine
    Rademaker, Alfred
    Gradishar, William John
    Santa-Maria, Cesar Augusto
    Jain, Sarika
    Flaum, Lisa E.
    Giles, Francis J.
    Yang, Hushan
    Cristofanilli, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Multiple biomarker expression in circulating tumor cells (CTCs) from locally advanced/inflammatory (LA/IBC) and metastatic breast cancer (MBC) patients (pts)
    Bruce, R. H.
    Hseih, H. B.
    Curry, D. N.
    Krivacic, R. T.
    Lazarus, N.
    Frankel, P.
    Lau, S.
    Somlo, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] The LiquidBiopsy in metastatic breast cancer (MBC): A novel diagnostic platform for next generation sequencing (NGS) of circulating tumor cells (CTCs)
    Strauss, William
    Winer-Jones, Jessamine
    Austin, Laura
    Dempsey, Paul W.
    Cristofanilli, Massimo
    [J]. CANCER RESEARCH, 2015, 75
  • [5] Circulating tumor cells (CTCs) and association with survival in molecular subtypes (MST) of metastatic breast cancer (MBC)
    Graham, M.
    Fleming, N.
    Pinto, A.
    Dropkin, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Circulating tumor cells (CTCs) and molecular subtypes (MST) in a treatment algorithm for metastatic breast cancer (MBC)
    Graham, Mark
    Fleming, Natanya
    Blumenthal, Susan
    Boehlke, Brittani
    Schuur, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
    Gradilone, A.
    Naso, G.
    Raimondi, C.
    Cortesi, E.
    Gandini, O.
    Vincenzi, B.
    Saltarelli, R.
    Chiapparino, E.
    Spremberg, F.
    Cristofanilli, M.
    Frati, L.
    Agliano, A. M.
    Gazzaniga, P.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (01) : 86 - 92
  • [8] Expression of CCR5 associated with HER2 in circulating tumor cells (CTCs) is a novel biomarker for patients with metastatic breast cancer (MBC)
    Zhang, Qiang
    Gerratana, Lorezo
    Shah, Ami N.
    Davis, Andrew A.
    Flaum, Lisa
    Zhang, Youbin
    Pestell, Richard G.
    Wehbe, Firas
    Behdad, Amir
    Platanias, Leonidas
    Gradishar, William
    Cristofanilli, Massimo
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [9] Isolation of Highly Pure Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients for Gene Expression Analysis.
    Magbanua, M. J.
    Hauranieh, L.
    Pendyala, P.
    Sosa, E.
    Scott, J.
    Rugo, H.
    Park, J.
    [J]. CANCER RESEARCH, 2011, 71
  • [10] Apoptotic Circulating Tumor Cells (CTCs) in early and metastatic breast cancer patients
    Kallergi, Galatea
    Konstantinidis, Georgios
    Papadaki, Maria
    Agelaki, Sophia
    Mavroudis, Dimitris
    Stournaras, Christos
    Georgoulias, Vassilis
    [J]. CANCER RESEARCH, 2011, 71
12345